https://seekingalpha.com/news/4105494-vaxart-up-10-quarterly-revenue-beat-eyes-covid-oral-vaccine-trial-start-q2?source=feed_sector_healthcare
May 13, 2024 - Vaxart (VXRT) reports strong Q1 results and plans to launch a phase 2 trial for its oral COVID-19 vaccine candidate this quarter. Read more here.
0
sa:5726784627860654057
0
https://www.zacks.com/stock/news/2273047/on-holding-onon-gears-up-for-q1-earnings-what-s-in-store?cid=CS-ZC-FT-analyst_blog|earnings_preview-2273047
May 13, 2024 - On Holding's (ONON) first-quarter 2024 results are likely to benefit from heightened brand demand, introduction of new stores and an expanding footprint in China.
zc:-6544982944136614243
0
https://www.zacks.com/stock/news/2273027/progressive-pgr-is-up-3-37-in-one-week-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2273027
May 13, 2024 - Does Progressive (PGR) have what it takes to be a top stock pick for momentum investors? Let's find out.
zc:-6608022605860293057
0
https://www.zacks.com/stock/news/2273101/avino-silver-asm-q1-earnings-beat-estimates-revenues-up?cid=CS-ZC-FT-analyst_blog|earnings_article-2273101
May 13, 2024 - Avino Silver & Gold Mines (ASM) witnesses an improvement in its bottom line in Q1 owing to cost control efforts as well as higher gold and silver prices.
zc:-4376454349582898871
0
https://seekingalpha.com/news/4105903-clover-health-mini-meme-stock-resurgence-up-27-in-past-two-sessions?source=feed_sector_healthcare
May 14, 2024 - Clover Health, part of the 2021 meme stock craze of 2021, is showing strong gains over the past two sessions on no apparent news. Read more here.
0
sa:-6623236085660858473
0
https://www.zacks.com/stock/news/2273734/albemarle-alb-martin-marietta-team-up-for-kings-mountain-mine?cid=CS-ZC-FT-analyst_blog|company_news_-_corporate_actions-2273734
May 14, 2024 - Teaser: Albemarle (ALB) and Martin Marietta collaborate to use limestone material from Kings Mountain Mine for sustainable construction projects.
zc:1045668791970833496
0
https://seekingalpha.com/news/4107020-aytu-bioscience-up-5-as-quarterly-results-beat-on-both-lines?source=feed_sector_healthcare
May 15, 2024 - Aytu BioScience (AYTU) reports fiscal Q3 results, beating expectations on both revenue and earnings, with a narrower net loss. Read more here.
0
sa:-3053512048603853143
0
https://www.zacks.com/stock/news/2274352/appfolio-appf-is-up-3-43-in-one-week-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2274352
May 15, 2024 - Does AppFolio (APPF) have what it takes to be a top stock pick for momentum investors? Let's find out.
zc:-1633538495539145735
0
https://www.fool.com/investing/2024/05/15/atlassian-stock-has-underperformed-over-the-last-5/?source=iedfolrf0000001
May 15, 2024 - A cheaper valuation and an improving outlook could deliver long-term gains for shareholders from here.
0
fool:-5963348026058667101
0